Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)
China
· Delayed Price · Currency is CNY 17.50
+0.12 (0.69%)
At close: Apr 28, 2025, 2:57 PM CST
Jiangsu CoWin Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Net Income | -161.38 | -84.41 | 159.26 | 125.85 | 108.16 | Upgrade
|
| Depreciation & Amortization | 39.09 | 33.3 | 23.25 | 15.73 | 4.6 | Upgrade
|
| Other Amortization | 4.07 | 3.94 | 3.06 | 2.31 | 1.66 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.19 | -1.24 | 0.51 | -1.29 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 6.43 | 4.27 | 0.06 | 0.03 | 0.03 | Upgrade
|
| Loss (Gain) From Sale of Investments | -14.61 | -26.71 | -7.94 | -7.57 | -3.27 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 20.8 | 9.51 | 1.6 | 0.77 | Upgrade
|
| Other Operating Activities | 23.07 | 8.94 | 16.85 | 3.13 | 0.14 | Upgrade
|
| Change in Accounts Receivable | -11.84 | 52.74 | -97.15 | -16.08 | -19.67 | Upgrade
|
| Change in Inventory | -19.48 | 17.55 | -23.29 | -9.6 | -6.07 | Upgrade
|
| Change in Accounts Payable | 21.91 | -43.75 | 14.18 | 20.47 | 17.83 | Upgrade
|
| Change in Other Net Operating Assets | 2.9 | 16.33 | 13.15 | 8.43 | 2.59 | Upgrade
|
| Operating Cash Flow | -113.26 | -11.72 | 107.37 | 144.5 | 108.89 | Upgrade
|
| Operating Cash Flow Growth | - | - | -25.70% | 32.70% | 4570.17% | Upgrade
|
| Capital Expenditures | -48.41 | -159.22 | -100.38 | -124.39 | -13.46 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.2 | 1.01 | 0.01 | 0.08 | - | Upgrade
|
| Cash Acquisitions | -13.83 | - | -5.21 | - | - | Upgrade
|
| Investment in Securities | 121.31 | -479 | -165 | 68.6 | -302.95 | Upgrade
|
| Other Investing Activities | 14.89 | 16.29 | 6.77 | 8.71 | 1.8 | Upgrade
|
| Investing Cash Flow | 74.16 | -620.91 | -263.81 | -47 | -314.6 | Upgrade
|
| Long-Term Debt Issued | 6 | - | - | - | 52.01 | Upgrade
|
| Long-Term Debt Repaid | - | -7.57 | -5.31 | -4.54 | -52.01 | Upgrade
|
| Net Debt Issued (Repaid) | 6 | -7.57 | -5.31 | -4.54 | - | Upgrade
|
| Issuance of Common Stock | 3.06 | - | 1,083 | - | 275 | Upgrade
|
| Common Dividends Paid | -3.9 | -50.73 | - | - | -32.58 | Upgrade
|
| Other Financing Activities | -58.06 | 6 | -19.27 | -3.22 | -0.91 | Upgrade
|
| Financing Cash Flow | -52.9 | -52.3 | 1,058 | -7.76 | 241.52 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.21 | 0.64 | 1.79 | -0.77 | -0.9 | Upgrade
|
| Net Cash Flow | -91.79 | -684.29 | 903.72 | 88.98 | 34.91 | Upgrade
|
| Free Cash Flow | -161.67 | -170.94 | 6.99 | 20.11 | 95.44 | Upgrade
|
| Free Cash Flow Growth | - | - | -65.25% | -78.93% | - | Upgrade
|
| Free Cash Flow Margin | -128.44% | -99.77% | 1.34% | 5.94% | 40.92% | Upgrade
|
| Free Cash Flow Per Share | -1.45 | -1.52 | 0.07 | 0.24 | 1.36 | Upgrade
|
| Cash Income Tax Paid | 5.66 | 23.45 | 36.72 | 17.62 | 20.34 | Upgrade
|
| Levered Free Cash Flow | -167.98 | -115.16 | -38.17 | -9.99 | 56.26 | Upgrade
|
| Unlevered Free Cash Flow | -167.98 | -114.1 | -36.96 | -8.79 | 56.33 | Upgrade
|
| Change in Net Working Capital | 65.23 | -78.64 | 86.26 | -7.3 | 11.83 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.